Related Experiment Video
Updated: Feb 6, 2026

Isolation and Identification of Waterborne Antibiotic-Resistant Bacteria and Molecular Characterization of their Antibiotic Resistance Genes
Published on: March 3, 2023
Identification of NMU as a potential gene conferring alectinib resistance in non-small cell lung cancer based on
1Department of Heart Failure, Research Center for Translational Medicine, Shanghai East Hospital, Tongji University School of Medicine, Shanghai 200120, China.
Abstract:
Non-small cell lung cancer (NSCLC) is the most common type of lung cancer, and adjuvant targeted therapy has shown great benefits for the NSCLC patients with specific genomic mutations. Alectinib, a selective anaplastic lymphoma kinase (ALK) inhibitor, has been clinically used for the NSCLC patients with ALK-rearrangement, however, irreversible therapeutic resistance for the patients receiving alectinib treatment frequently occurs. Here we show that neuromedin U (NMU) may confer the alectinib resistance in NSCLC via multiple mechanisms based on the integrative bioinformatics analyses. Through employing the bioinformatics analyses of three microarray datasets, NMU, overexpressed in both NSCLC tissues and alectinib-resistant NSCLC cells, was initially identified as potential candidate for causing alectinib resistance in NSCLC. The resistance function of NMU in NSCLC was validated by performing protein/gene interactions and biological process annotation analyses, and further validated by analyzing the transcription factors targeting NMU mRNA. Collectively, these results indicated that NMU may confer alectinib resistance in NSCLC.
Insights
Neuromedin U (NMU) may cause resistance to alectinib, a targeted therapy for non-small cell lung cancer (NSCLC). This discovery, based on bioinformatics, offers insights into overcoming treatment challenges in NSCLC patients with ALK-rearrangements.
Area of Science:
- Oncology
- Molecular Biology
- Bioinformatics
Background:
- Non-small cell lung cancer (NSCLC) is a prevalent malignancy.
- Targeted therapies like alectinib offer benefits for NSCLC patients with specific genomic alterations, such as anaplastic lymphoma kinase (ALK) rearrangements.
- Therapeutic resistance to alectinib is a significant clinical challenge, limiting treatment efficacy.
Purpose of the Study:
- To identify potential mechanisms contributing to alectinib resistance in NSCLC.
- To investigate the role of neuromedin U (NMU) in conferring resistance to alectinib treatment.
- To explore NMU as a therapeutic target for overcoming alectinib resistance.
Main Methods:
- Integrative bioinformatics analysis of three microarray datasets.
- Identification of NMU as a candidate gene overexpressed in NSCLC and alectinib-resistant cells.
- Validation through protein/gene interaction analysis, biological process annotation, and transcription factor analysis.
Main Results:
- Neuromedin U (NMU) was identified as significantly overexpressed in both NSCLC tissues and alectinib-resistant NSCLC cell lines.
- Bioinformatics analyses supported NMU's role in conferring alectinib resistance through multiple mechanisms.
- Further analysis confirmed the involvement of transcription factors regulating NMU mRNA expression.
Conclusions:
- Neuromedin U (NMU) is implicated as a key factor in the development of alectinib resistance in non-small cell lung cancer.
- Targeting NMU may represent a novel therapeutic strategy to overcome alectinib resistance in NSCLC patients with ALK-rearrangements.
- These findings provide a basis for further experimental validation and clinical investigation.
More Related Videos
Related Concept Videos
Treatment Resistant Cancers
Gene Flow
Cell Potential and Free Energy
Thermodynamics is the branch of physics dealing with the relationship between heat and other forms of energy. In an electrochemical cell, chemical energy is converted into electrical energy.
Thus, a link can be predicted between cell potential, free energy change, and the equilibrium constant for the reaction. Cell potential can also be measured as the oxidant or the reducing strength, and similar acid-base strength measures are reflected in equilibrium...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cell Specific Gene Expression

